The Trump administration sought Friday to alleviate fears about the availability of mass testing for the coronavirus, with Vice President Mike Pence telling reporters that states "have enough tests to implement the criteria of phase one" of the White House plan to reopen the economy "if they choose to do so."A slide in the White…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.Several states have started to outline how they will reopen after a month of lockdown measures designed to combat the coronavirus pandemic.While some states have yet to see their peak, others have managed to flatten the curve, with Gov. Andrew Cuomo saying…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f